Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: J Cardiovasc Pharmacol. 2012 Jun;59(6):487–499. doi: 10.1097/FJC.0b013e31824ba6b5

Fig. 5.

Fig. 5

Validation of selected genes by western blotting. (A) CASMC and (B) HCAEC cells were treated with NSAIDs for 24h. COX-2 (top panel) and thrombomodulin (TM) (lower panel) protein levels were analyzed by western blotting. Data shown are representative of 3 separate experiments. Δ Western: fold change by western blot analysis. Δ Microarray: fold change by microarray analysis.